1. Home
  2. Medical Research
  3. Boston, MA
  4. Scleroderma Clinical Trials Consortium
AMERICA'S BEST NONPROFITS 2026

Scleroderma Clinical Trials Consortium

Scleroderma Clinical Trials Consortium is ranked #1 of 12 medical research organizations in Boston, MA, with an America's Best Score of 100 out of 100, based on its 2024 Form 990. It's named America's Best 2026.

  • Boston, MA
  • Tax-exempt since 2001
  • EIN: 04-3543489
sctconline.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
100OF 100 #1 of 12 in Boston ranked medical research organizations How this score is calculated

Organization summary

Scleroderma Clinical Trials Consortium is a 501(c)(3) organization, classified under Medical Research (NTEE H99). Contributions are tax-deductible.

Bu Sch Medicine 718 Albany St E-5, Boston, MA 02118-0000

Among the 13 scored medical research organizations in Boston, Scleroderma Clinical Trials Consortium holds 160 months of operating reserves (peer median 14.1 months), runs a typical yearly surplus of 25.8% (peers: surplus of 25.8%), and has grown spending 29.7% a year (peers: grown spending 11.8% a year).

In fiscal year 2024 it reported $326,433 in revenue and $298,602 in expenses, with contributions making up 66.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

To foster scientific research and to advance medical research in the form of treatment trials in scleroderma on a worldwide basis.

Main program · fiscal year 2024

  • To foster scientific research and to advance medical research in the form of treatment trials in scleroderma on a worldwide basis. $286,656 spent

Where each dollar went · fiscal year 2024

Of every dollar it spent, 96¢ went to programs, 4¢ to management and 0¢ to fundraising.

  • Programs $286,656
  • Management $11,946
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score100 / 100
Rank in Boston#1 of 12
DesignationAmerica's Best 2026

Score breakdown

MeasureThis organizationPoints
Operating reserves160.0 months25 / 25
Financial balance (median margin)+25.8%20 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+29.7% / yr15 / 15
Track record25 years10 / 10
Debt load1.2% of assets10 / 10
Total100 → 100

Compared with Boston peers

MeasureThis organizationPeer median
Operating reserves160.0 mo14.1 mo
Typical margin+25.8%+25.8%
Spending growth+29.7% / yr+11.8% / yr
Debt load1.2%6.0%

Peers: the 13 Boston medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$326,433Fiscal year 20242022: $271,98120222023: $264,48420232024: $326,4332024
Expenses$298,602Fiscal year 20242022: $177,44120222023: $210,24220232024: $298,6022024
Total assets$4,030,611Fiscal year 20242022: $2,536,41020222023: $3,466,89420232024: $4,030,6112024
Total liabilities$50,000Fiscal year 20242022: $020222023: $876,24220232024: $50,0002024
Fiscal year ending December 2024
Revenue$326,433
Expenses$298,602
Net income$27,831
Net assets$3,980,611

Notable sources of revenue

Percent of total revenue
Contributions$217,229
Program services$0
Investment income$109,204
Other (net)$0

Assets / debt

Total assets$4,030,611
Total liabilities$50,000
Net assets$3,980,611

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$264,484
Expenses$210,242
Net income$54,242
Net assets$2,590,652

Notable sources of revenue

Percent of total revenue
Contributions$188,821
Program services$0
Investment income$75,663
Other (net)$0

Assets / debt

Total assets$3,466,894
Total liabilities$876,242
Net assets$2,590,652

Compensation

Officers and key employees$0
Share of expenses0.0%
Fiscal year ending December 2022
Revenue$271,981
Expenses$177,441
Net income$94,540
Net assets$2,536,410

Notable sources of revenue

Percent of total revenue
Contributions$188,315
Program services$0
Investment income$83,666
Other (net)$0

Assets / debt

Total assets$2,536,410
Total liabilities$0
Net assets$2,536,410

Compensation

Officers and key employees$0
Share of expenses0.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?